Latest News

Journal Articles

Brain and neurologic

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

Brain cancer dataset made freely accessible to global researchers

Checkpoint blockade immunotherapy doubles survival for melanoma brain metastases patients

Breast

Tamoxifen, SERMs and sustainable medicine: an interview with V. Craig Jordan & Balkees Abderrahman

3D printed life-sized breast cancer tumors created

Triple-negative breast cancer risk genes discovered

Colorectal

Chemicals found in vegetables prevent colon cancer in mice

Colorectal cancer screening age to be lowered to 50 in England

ASCO18: PRODIGE 7 demonstrates that HIPEC may not be necessary for CRC patients

Endocrine

Blood test could detect kidney cancer up to 5 years earlier

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

FDA approves first-in-class treatment for rare adrenal tumors

Gastrointestinal

Conference Chair highlights: World Congress on Gastrointestinal Cancer

ESMO WCGI: Trifluridine and tipiracil show promise as metastatic gastric cancer treatment in Phase III trial

New blood test could detect eight types of cancer

Genitourinary

NICE approves atezolizumab for advanced bladder cancer patients on the NHS

Breakthrough method to diagnose prostate cancer developed

Researchers uncover 80 potential ways of targeting prostate cancer

Gynecologic

Targeting BRAF mutations to treat ovarian cancer

Ovarian cancer progression delayed by Lynparza® treatment

Vaccine success for cervical cancer: study reports fall in HPV infections

Head and neck

Diabetics face a higher risk of mouth cancer, with women more at risk

The importance of a multidisciplinary team in the care of head and neck cancer

The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer

Hematologic

Increased risk of myeloid blood cancers in relatives of patients

Comprehensive CAR T-cell therapy pediatric guidelines developed

Non-Hodgkin lymphoma: infographic

Lung

Chinese regulators approve Alecensa® for NSCLC, hot on heels of FDA and EMA approvals

Cost–effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve access

Novel lung cancer MRI technique shows promise for improving radiotherapy treatment planning

Pancreatic

ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer

ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer

Prostate

Hair loss gene could be exploited to improve cancer immunotherapy

Lab-grown tumors accelerate prostate cancer research

New FDA oncology drug approvals and indications

Rare tumors

Osteoblastoma genetic marker shows promise for identifying aggressive tumors

Best of ASCO18: key takeaways & the practice-changing talks

Practice-changing breakthrough made for rare cancer

Skin

Hair loss gene could be exploited to improve cancer immunotherapy

New FDA oncology drug approvals and indications

Checkpoint blockade immunotherapy doubles survival for melanoma brain metastases patients